1Lawrence GT, George DJ. Transfusion medicine:support of patient undergoing cardiac surgery[J]. Am J Cardiovasc Drugs, 2001, 1(5): 337 被引量：1
2Edward C. Perioperative use of erythropoietin[J]. Am J Therap, 2002, 9(5): 371 被引量：1
3Abdelrahman M, Sharpies EJ, McDonald MC, et al.Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia [J].Shock,2004,22(1) :63 被引量：1
4Chanil Moon, Melissa Krawczyk,Dongchoon Ahn, et al.Erythropoietin reduced myocardiol infarction and left ventricular functional decline after coronary artery ligation in rats[J]. Proc Natl Acad Sci USA,2003,100(20):11612 被引量：1
5Lipsic E, van der Meer P, Henning RH,et al. Timming of erythropoietin treatment of cardioprotection in ischemia/reperfusion[J]. J Cardiovasc Pharmacol, 2004, 44(4) :473 被引量：1
6Zhao ZC, Jing QK, Kenneth M. Erythropoietin is a novel vascular protectant through activation of aktl and mitochondrial modulation of cysteine proteases[J]. Circulation, 2002, 106(23): 2973 被引量：1
7Cai Z, Semenza GL. Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion Injury[J].Circulation, 2004,109(17): 2050 被引量：1
8Tramontano AF, Muniyappa R, Black AD, et al. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an akt-dependent pathway[J]. Biochem Biophys Res Commun,2003,308(4):990 被引量：1
9Fiordaliso F, Chimenti S, Staszewsky L, et al. A nonerythropoietic derivation of erythropoietin protects myocardium from ischemia-reperfuslon injury[J]. Proc Natl Acad Sci USA,2005,102(6):2046 被引量：1
4Azhar G, Liu L, Zhang X, et al. Influence of age on hypoxia/reoxiygenation-induced DNA fragmentation and Bcl-2, Bcl-xl, Bax and Fas in the rat heart and brain[J].Mech Aging Dev,1999,112:5. 被引量：1
5Agnello D, Bigini P, Villa P, et al. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model model of experimental autoimmune eneephalitis[J]. Brain Res,2002, 952:128. 被引量：1
6Wu H, Lee SH, Gao J, et al. Inactivation of erythropietin leads to defects in cardiac morphogenesis[J]. Development, 1999, 126:3597. 被引量：1
7Jaquet K, Krause K, Tawakol-Khodai M, et al. Erythropoietin and VEGF exhibit equal angiogenic potential[J].Microvasc Res, 2002, 64:326. 被引量：1
8Juul S. Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage[J]. Acta Paediatr Suppl, 2002, 91:36. 被引量：1
9Yang CW, Li C, Jung JY, et al. Preconditioning with erythropoietin protects against subsequent ischemiareperfusion injury in rat kidney[J]. FASEB J, 2003, 17:1754. 被引量：1
10Tramontano AF, Muniyappa R, Black AD, et al. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway[J]. Biochem Biophys Res Commun,2003, 308, 990. 被引量：1
